Tech Company Financing Transactions
Faeth Therapeutics Funding Round
Faeth Therapeutics secured a $20 million Seed funding round on 1/27/2022. Backers included Future Ventures, Khosla Ventures and AgFunder.
Transaction Overview
Company Name
Announced On
1/27/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Seed
Investors
Future Ventures (Lead Investor)
Khosla Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
237 Kearny St. 9245
San Francisco, CA 94108
USA
San Francisco, CA 94108
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Faeth was born from three leading research teams with three separate discoveries coming together around one big idea: We can use metabolism to beat cancer.? Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anand Parikh
VP - R & D
Oliver Maddocks
Browse more venture capital transactions:
Prev: 1/27/2022: Spyke Games venture capital transaction
Next: 1/27/2022: AiVidens venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs